FineMark National Bank & Trust’s Protolabs PRLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-1,732
Closed -$89K 842
2016
Q4
$89K Sell
1,732
-36
-2% -$1.89K 0.01% 501
2016
Q3
$106K Sell
1,768
-220
-11% -$12.7K 0.01% 445
2016
Q2
$114K Buy
1,988
+6
+0.3% +$400 0.01% 405
2016
Q1
$153K Sell
1,982
-174
-8% -$11.2K 0.02% 342
2015
Q4
$137K Buy
2,156
+116
+6% +$7.48K 0.02% 382
2015
Q3
$137K Sell
2,040
-74
-4% -$5.27K 0.02% 385
2015
Q2
$143K Sell
2,114
-19
-0.9% -$1.34K 0.02% 402
2015
Q1
$149K Buy
2,133
+871
+69% +$59K 0.02% 398
2014
Q4
$85K Sell
1,262
-59
-4% -$3.88K 0.01% 521
2014
Q3
$91K Buy
1,321
+133
+11% +$10.4K 0.01% 499
2014
Q2
$97K Buy
1,188
+84
+8% +$5.69K 0.02% 476
2014
Q1
$75K Buy
1,104
+83
+8% +$6.17K 0.01% 513
2013
Q4
$73K Buy
1,021
+12
+1% +$930 0.02% 497
2013
Q3
$77K Buy
1,009
+47
+5% +$3.25K 0.02% 479
2013
Q2
$63K Buy
+962
New +$51.7K 0.02% 513

Other funds holding PRLB

FineMark National Bank & Trust's PRLB Position: Q1 2017 in Review

FineMark National Bank & Trust sold out of Protolabs (PRLB) in Q1 2017, closing a stake of 1,732 shares — an estimated $89K sold.

FineMark National Bank & Trust first reported a position in PRLB in Q2 2013 and held it in 15 quarters. The position peaked at $153K in Q1 2016. 184 funds tracked by Wall St. Rank hold PRLB as of Q1 2017.

  • FineMark National Bank & Trust reported no remaining Protolabs position as of Q1 2017 after selling out during the quarter.
  • FineMark National Bank & Trust sold 1,732 Protolabs shares in Q1 2017, an estimated $89K.
  • FineMark National Bank & Trust first reported a position in Protolabs in Q2 2013 and held it in 15 quarters.
  • FineMark National Bank & Trust's Protolabs position peaked at $153K in Q1 2016.
  • 184 funds tracked by Wall St. Rank held Protolabs as of Q1 2017.

Based on FineMark National Bank & Trust's 13F filing for Q1 2017, filed 12 May 2017.